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Lead, Blood Pressure, and Cardiovascular
Disease in Men and Women
by Joel Schwartz*
Lead has been shown to be associated with elevated blood pressure in males in the NHANES II
survey and innumerous otherstudies. This study confirms theassociationinmalesaged 20 to 74 and
documents a significant, although weaker, association in females as well. Prospective cardiovascu-
lar disease studies such as the Framingham study indicate that increases in blood pressure should
be associated with increased risk of cardiovascular disease. Using electrocardiogram data from
NHANES II, this study confirms the expected association oflead with left ventricular hypertrophy
(p < 0.01). Such an association with permanent cardiovascular changes adds weight to the blood
pressure findings. The logistic risk coefficients from the Framingham study can be combined with
the study's association between lead and blood pressure to examine its implication for more serious
outcomes. The results suggest that a halving ofthe population mean blood lead level would reduce
myocardial infarctions by approximately 24,000 events per year and incidence ofall cardiovascular
disease by over 100,000. These numbers suggest a small attributable risk compared to the vast in-
cidence ofcardiovascular disease inthe U.S., but alarge attributable riskcompared to most environ-
mental toxins. Several biological mechanisms have been identified, with different implications for
the use of bone lead as an exposure measure.
Introduction
While numerous studies in animals and humans
have implicated lead exposure as afactor inincreasing
blood pressure, they have often focused only on males
and on restricted age ranges. Studies of direct cardio-
vascular outcomes have been hampered by the low rel-
ative risks impliedby the blood pressure relationships
that have been found. To address these issues, data
from the Second National Health and Nutrition Ex-
amination Survey (NHANES II) were examined for
males and females aged 20 years and older. The
NHANES II included electrocardiograms as well as
blood pressure measurements, and the association of
lead with both outcomes was examined. This allowed
a direct examination ofthe assumption that increased
blood pressure due to lead will have cardiovascular
implications.
subsample of9932 subjects. Extensive analyses ofthe
relationship between blood lead and blood pressure in
males have been presented previously (2-4), and they
provide details of the medical history questionnaire,
bloodbiochemistry methods, dietary information, and
physical examinations.
Electrocardiograms were performed on all subjects
aged 25 to 74 years using a standard 12-lead ECG. Re-
sultsweredigitallyencodedandthenclassifiedaccord-
ing to the Minnesota Codes of Electrocardiographic
Findings (5) usingthe Novacoderprogram ofDalhousie
University (6,7). Using variables identified as impor-
tant in those earlier studies, the relationship between
blood lead and blood pressure was examined in both
males and females, aged 20 to 74 years. Table 1 shows
the covariates considered in the analysis.
The blood pressure data were analyzed in stages.
First, separate regressions were performed for males
Data and Methods
The Second National Health and Nutrition Examin-
ation Survey was conducted between February 1976
andFebruary 1980. The sample waschosentobe repre-
sentative ofthe civilian, noninstitutionalized U.S. pop-
ulation, aged 6 months to 74 years. Medical histories,
serum biochemistries, and dietary questionnaires
were obtained (1). Blood lead levels were obtained on a
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Table 1. Variables considered in the regressions.
Age, years In (serum zinc)
Racea In (blood lead)
Sexb Dietary potassium
Body mass index, kg/m2 Dietary sodium
Cigarettes/day Serum cholesterol
Tricep skinfold, mm Height, m
Family history ofhypertension In (dietary vitamin C)
Recreational exercisec
a 2 = Black, 1 = white.
b Left ventricular hypertrophy regression: 2 = female, 1 = male.
c 1 = Little, 2 = moderate, 3 = substantial.J SCHWARTZ
andfemales. Diastolic bloodpressure wasregressedon
age, age2, race, Quetelet's body mass index (weight/
height2), and the natural logarithm of blood lead. If
lead was significant in this first step, then a stepwise
regression was performed, using the variables shown
in Table 1. An interaction term was used to assess the
possibility of a racial difference in the effect of lead.
Final models were estimated using SURREGR, a pro-
gram that incorporates the design effects in the study
(8).
The probability of left ventricular hypertrophy was
modeled using logistic regression. Since the definition
of left ventricular hypertrophy incorporates body ha-
bitus, body mass index andtricep skinfold were not in-
cluded in these regressions. Stepwise logistic regres-
sion ofthe remainingcovariates inTable 1 was usedto
identify a model. The design effects were incorporated
usingRTILOGIT (9). Because ofthe limitednumber of
cases, sex differences in any lead effect were investi-
gated using an interaction term. An interaction term
was also used to test for racial differences.
Results
Blood lead was a significant predictor ofblood pres-
sure inbothmales(p < 0.01)andfemales(p < 0.01) in
the first-stage regressions, controlling for age, race,
andbody mass index. In separate stepwise regressions
formalesandfemales,leadcontinuedtobe significant-
ly related to diastolic blood pressure. The final models
for blood pressure, incorporating the design effects of
the survey, are shown onTable 2. While the coefficient
ofblood lead was lower in females than in males, the
difference in magnitudes is not significant. This was
Table 2. Regression results for diastolic blood pressure.
Variable Coefficient SE p-value
Males
Intercept 29.86 10.90
Age 0.6073 0.0887 <0.0001
Age' -0.0057 0.0010 <0.0001
Body mass index 0.7312 0.0932 <0.0001
Race 1.549 0.8955 0.0934
Family history 2.543 0.4210 <0.0001
Cholesterol 0.0247 0.0071 0.0016
Blood leada 2.928 1.002 0.0063
Height 12.89 3.251 0.0004
Cigarettes -0.057 0.023 0.0183
Zinc -4.37 1.491 0.0062
Tricep 0.0110 0.005 0.0490
Females
Intercept 57.64 7.578
Age 0.6135 0.1105 <0.0001
Age2 -0.005 0.0012 0.0001
Body mass index 0.6857 0.0582 <0.0001
Race 2.408 0.7920 0.0047
Zinc -5.54 1.646 0.0020
Family history 1.145 0.3688 0.0040
Blood leada 1.640 0.6963 0.0247
Tricep 0.0084 0.0035 0.0203
Cholesterol 0.0113 0.0055 0.0477
a Natural logarithm.
Table 3. Logistic regression results:
left ventricular hypertrophy.
Variable Coefficient SE p-value
Intercept -3.94 0.5081
Age 0.0140 0.0052 0.0117
Race 1.357 0.2017 <0.0001
Sex -1.01 0.1649 <0.0001
Lead 0.0283 0.0100 0.0087
confirmed in a regression withboth sexes, using an in-
teraction term to test for a different slope. The inter-
action was insignificant (p > 0.30). An interaction
termforrace wassimilarlyinsignificant. Racewasnot
significant inthe regressionformales, presumablybe-
cause racial differences in the biological risk factors
explainedtheracial difference inbloodpressure. Since
blacks have higher blood lead levels than whites, the
race term was forced into the regression to give a con-
servative estimate ofthe effect of lead.
Bloodleadwasalsoasignificant predictorofleftven-
tricularhypertrophy. Table 3 showsthe logistic regres-
sion model, incorporatingthe designeffects. The inter-
actiontermsforsexorracedifferencesinthecardiovas-
cular effects oflead were also insignificant (p > 0.20).
As in previous analyses (2,3), the natural logarithm
ofblood lead was more significant than blood lead in
predicting blood pressure. This implies a relationship
with a largermarginal impact ofbloodleadchanges at
low blood lead levels than at high blood lead levels. In
contrast,the linearformofbloodleadwasmoresignifi-
cant as a predictor of left ventricular hypertrophy.
Discussion
The existence of a strong association between blood
lead and blood pressure across the entire adult age
range has already been noted in males in this survey.
This analysis demonstrates that a significant associa-
tion is present in females as well. The association ap-
pears somewhat weaker in magnitude and in signifi-
cance level than that for males. While most other epi-
demiology studies have focused on males, Rabinowitz
etal.(10)havereportedanassociationofleadwithboth
bloodpressureandpregnancyhypertensioninfemales.
Victery et al. (11) have reported a sex difference in the
effect oflead on blood pressure in rats, with insignifi-
cant effects in females. However, Perry and Erlander
(12) have reported a significant association in female
rats, in a diet lower in calcium.
A large body ofexperimental data, both in vivo and
in vitro, shows that lead increases blood pressure in
several speciesofrats,pigeons, anddogs(13-18). These
studies have also documented increased reactivity to
alpha adrenergic stimulation (14,16) and an interac-
tionwithcalciummetabolism(15). Many ofthese stud-
ies examined several dose levels, and Victery (19) has
summarized them as indicating biphasic response,
with a strong effect of low-level exposure that disap-
pears at high levels. A similiar pattern has been seen
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in the pressor effects ofcadmium (20). These findings
in the experimental literature are consistent with the
logarithmic dose-response relationship found in this
study.
Prospective studiesofcardiovasculardisease, suchas
the Framingham study (21), clearly demonstrate that
the risk ofcardiovascular disease varies continuously
with blood pressure. No plausible reason exists to as-
sumethatincreases inbloodpressure due toleadexpo-
sure would not have the same impact. Studies of the
use ofdrugtherapy toreduce bloodpressure have been
more mixed, withthe Hypertension Detection andFol-
lowup Study(22)findingsignificant reductions inrisk,
but not the MRFIT study (23). However, hypertensive
medication has adverse side effects, including distur-
bances ofpotassiummetabolism, that may counteract,
in whole or part, the beneficial impacts ofblood pres-
sure reduction. Reducing lead exposure has no similar
counter-risk, since leadhasonlyharmful effects inthe
body. Ittherefore seems prudent to assume thatreduc-
ing body lead burdens will reduce blood pressure and
cardiovascular disease in both the new generation of
adults whowill notbecome exposed, aswell asthe cur-
rent one, whose exposure will be reduced.
Nevertheless, direct evidence for a cardiovascular ef-
fectofleadwouldclearly strengthentheseconclusions.
The regression coefficients in Table 2 indicate that a
halvingofbloodleadlevelsintheU.S. wouldreducethe
mean male blood pressure by over 2 mm Hg, and the
mean female blood pressure by over 1 mm Hg. The
logistic risk coefficients from the Framingham study
predict that these changes would result in about
24,000 fewer myocardial infarctions per year, and over
100,000 fewer cases of cardiovascular disease. While
these are large numbers compared to most risk assess-
ments for environmental toxins, they represent rela-
tiverisksofabout 1.05 duetothehighbackgroundrate
ofthese outcomes. Such relative risks are unlikely to
be detected in any prospective study. Electrocardio-
gram abnormalities indicative of left ventricular hy-
pertrophy represent an early indicator of cardiovas-
cular disease that is more common than myocardial
infarctions. Leftventricularhypertrophy isalsoaprev-
alence, rather than incidence measure. This increases
the power to detect a direct cardiovascular impact of
lead. The finding of a significant association between
blood lead levels and left ventricular hypertrophy in
both menandwomenleaves littledoubtthatleadexpo-
sure isnotmerelyraisingbloodpressurebutproducing
the expected cardiovascular impacts.
While cardiovascular effects of lead intoxication
have long been noted, ECG outcomes have been stud-
ied infrequently at the exposure levels ofcurrent con-
cern. Kirkby and Gyntelberg(24)noted a 20% increase
(p < 0.01) in ischemic changes, as coded onthe Minne-
sota Codes, in lead workers compared to controls
matched on age, race, sex, height, weight, alcohol con-
sumption, and smoking. Kopp (25), in an ECG study of
rats, foundprolonged PRintervals, depressed contract-
ility and protein phosphorylation, and high energy
phosphate levels. Hejtmancik and Williams (26) have
reported increased susceptibility to arrhythmias in
lead-exposed rats. While not directly parallel, Khera
(27) did note increased blood and urine lead levels in
cardiovascular patients compared to hospital controls.
Potential Mechanisms and Bone Lead
The experimental studies provide more than simple
biological support for the epidemiological findings.
They also provide insight into several possible biolog-
icalmechanismsfortheeffectofleadonbloodpressure.
Thetwomajormodes ofaction identifiedare inthe cal-
cium metabolism of the vascular smooth muscle and
renal effects mediated through the renin-angiotensin
system. In addition, direct cardiovascular effects may
also occur.
Piccinini andco-workers(18)foundthat lead induced
contraction and hyper-reactivity in perfused rat tail
arteries. Tissue analysis indicated the lead-exposed
vascular smooth muscle cells had increased free cyto-
solic calcium and increased total calcium stores. This
isconsistent withthefindingthatleadincreasescellu-
lar calcium concentration in brain capillaries (28),
neurons (29), hepatocytes (30), and other tissues. Hy-
per-reactivity has also been noted by Iannaconne and
co-workers (31), Carmignani et al. (14), Boscolo and
Carmignani (31), and Webb and associates (16). These
findings suggestamechanismwithincreasedintracel-
lularcalciumstores, leadingtoincreasedreleaseofcal-
cium in response to stimulation, and hence increased
contractility via calcium's role in mediating muscle
contraction. Supportingthishypothesis istheobserva-
tion ofChai and Webb (32)that methoxamine-induced
contractions in the tail arteries of lead-exposed rats
were less sensitive tocalciumchannelblockers andre-
laxed at a slower rate than unexposed arteries.
Asecondmodeofactionforleadindisturbingthecal-
cium-mediated control ofvascular reactivity and ten-
sionmaybeviadisturbance ofproteinkinaseC metab-
olism. Markovac and Goldstein (33) have shown that
lead activates protein kinase C in rat brain microves-
sels. Protein kinase C is involved in the phosphoryla-
tion of proteins involved in contraction (34). Recent
studiesbyChaiandWebb(32)haveshownthatisolated
strips of rabbit tail artery contracted in response to
lead. This contractile response was enhanced by pro-
tein kinase C activators, but attenuated by a selective
inhibitor ofprotein kinase C.
Both of the above mechanisms seem dependent on
the current concentration oflead at the membrane or
in the cytosol ofthe smooth muscle cell. This suggests
thatthe appropriate measure ofexposure isonethat is
relatively contemporaneous. Blood lead is such a mea-
sure. The entire effect cannot be considered instanta-
neous, sincebothVictery andcolleagues(11)andPerry
andErlanger(12)foundthat ratbloodpressure did not
reach its equilibrium elevation until several months
after blood lead levels equilibrated. Bone lead mea-
surements that are targeted to shorter residence com-
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partments, possibly includingtrabecular bone, may be
a superior measure ofexposure, but this remains to be
seen.
A mechanism more consistent with cumulative ex-
posure measures postulates permanent kidney chang-
esresultingineffects onthe renin-angiotensin system.
The animal and human data on the effect of lead on
this system are confusing, with findings of both in-
creased and decreased plasma renin activity following
lead exposure. Vander and associates (35) have postu-
lated anelevation ofplasma renin activity upon initial
exposure, followed by an eventual reduction after
chronic exposure. This hypothesis comes closest to
making sense out of the conflicting data and accords
with the finding of Boscolo and Carmignani (14) of a
similar pattern in human exposure.
All or some ofthe above mechanisms may be impor-
tant in lead-induced hypertension, but they are con-
sistentwithdifferent averagingtimesforthebestmea-
sure ofexposure. It seems most likely that short-term
exposure andaltered calcium metabolism are the most
important pathways for blood pressure elevation. Car-
diovascular outcomes seem likely to vary with dura-
tion as well as level ofblood pressure change, suggest-
ing a more cumulative exposure measure would be ap-
propriate for them. Finally, it should be noted that
Revis et al. (15) found lead associated with atheroscle-
rosis inpigeons. These findings, plus some ofthe direct
cardiovascular effects noted by Kopp (25), also suggest
thatcumulative measures ofleadmaybe importantfor
assessing cardiovascular disease. Final resolution of
the appropriate exposure measure will await studies
that use all ofthem.
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